Freestone Grove Partners’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-473,381
Closed -$7.46M 974
2025
Q4
$7.46M Buy
473,381
+139,207
+42% +$2.48M 0.05% 317
2025
Q3
$6.47M Buy
334,174
+220,991
+195% +$4.32M 0.05% 322
2025
Q2
$2.34M Buy
+113,183
New +$2.35M 0.02% 365
2025
Q1
Sell
-147,985
Closed -$3.54M 580
2024
Q4
$3.54M Buy
+147,985
New +$4.7M 0.04% 248

Other funds holding AMN

Freestone Grove Partners's AMN Position: Q1 2026 in Review

Freestone Grove Partners sold out of AMN Healthcare (AMN) in Q1 2026, closing a stake of 473,381 shares — an estimated $7.46M sold.

Freestone Grove Partners first reported a position in AMN in Q4 2024 and held it in 4 quarters. The position peaked at $7.46M in Q4 2025. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

  • Freestone Grove Partners reported no remaining AMN Healthcare position as of Q1 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 473,381 AMN Healthcare shares in Q1 2026, an estimated $7.46M.
  • Freestone Grove Partners first reported a position in AMN Healthcare in Q4 2024 and held it in 4 quarters.
  • Freestone Grove Partners's AMN Healthcare position peaked at $7.46M in Q4 2025.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.